Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07211230 · ClinicalTrials.gov registry record
Collagenase Biobank Study
A clinical trial, sponsored by University of Chicago.
- Not yet
- Registry status
- 107
- Enrollment target
NCT07211230 is a clinical trial that has not yet begun recruiting, run by University of Chicago. The registered enrollment target is 107 participants.
The verdict
NCT07211230 has not yet begun recruiting, sponsored by University of Chicago.
- NOT YET RECRUITING
- Registry status
- 107 participants
- Enrollment target
Study Summary
The purpose of this study is to look at how bacteria present within the stool at the time of surgery and postoperatively may contribute to the development of cancer recurrence after surgery. By collecting stool and blood before and after surgery, the researchers hope to determine if certain types of bacteria, or products that the bacteria produce, promote the development of tumors after surgery. By collecting tumor tissue and growing cell lines, we hope this will help researchers better understand the behavior of these types of tumors.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2026-08 |
| Est. Completion | 2026-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07211230
The ClinicalTrials.gov registry entry for NCT07211230 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07211230 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07211230 about?
NCT07211230 is a clinical study titled "Collagenase Biobank Study". The purpose of this study is to look at how bacteria present within the stool at the time of surgery and postoperatively may contribute to the development of cancer recurrence after surgery. By collecting stool and blood before and after surgery, the researchers hope to determine if certain types of...
What is the current status of trial NCT07211230?
This trial is currently not yet recruiting. The enrollment target is 107 participants. The study started on 2026-08. Estimated completion is 2026-10.
Who is sponsoring clinical trial NCT07211230?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.